Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Fluad 2012-2013 influenza vaccine in elderly subjects
2012-000085-38Phase 2Terminated
- Sponsor
- Novartis
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Novartis. Primary endpoints: Local and systemic reactions after vaccination, Adverse events and serious adverse events and 5 more. Started Mar 2012; status: terminated.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-000085-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000085-38.